Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David Cladingboel is active.

Publication


Featured researches published by David Cladingboel.


Bioorganic & Medicinal Chemistry Letters | 1994

Synthesis and evaluation of dual domain macrocyclic FKBP12 ligands.

Moya Caffrey; David Cladingboel; Martin Cooper; David Keith Donald; Mark Furber; David Norman Hardern; Richard P. Harrison; Michael J. Stocks; Simon J. Teague

Abstract A number of dual domain, macrocyclic FKBP12 ligands were synthesised in which the FK506 effector domain was fused to simplified FKBP12 bindings domains. The resulting macrocyclic compounds possessed moderate binding affinities for FKBP12 but showed no activity in an assay for FKBP12 dependent calcineurin inhibition.


Bioorganic & Medicinal Chemistry Letters | 1994

Synthetic FKBP12 ligands. Design and synthesis of pyranose replacements.

Timothy N. Birkenshaw; Moya Caffrey; David Cladingboel; Martin Cooper; David Keith Donald; Mark Furber; David Norman Hardern; Richard P. Harrison; David Peter Marriott; Matthew W.D. Perry; Michael J. Stocks; Simon J. Teague; W.John Withnall

Abstract A number of FKBP12 ligands were designed and synthesised and their affinity for FKBP12 assessed. In these ligands the pyranose ring of FK506 was replaced by other more synthetically accessible groups. The preparation of suitable intermediates for the synthesis of “dual domain” inhibitors (compounds 6a–c, 15 and 22) is also described.


Tetrahedron | 1994

Tandem radical cyclisations : Synthesis of lysergic acid derivatives

Yusuf Özlü; David Cladingboel; Philip J. Parsons

Abstract A novel free radical cyclisation approach for the synthesis of lysergic acid analogues has been investigated. The homolytic cleavage of carbon-bromine bond, mediated by tri-n-butyltin hydride, led to the development of a method for the construction of 3,4-disubstituted dihydroindoles via single cyclisation; hexahydrobenz[cd]indoles via double tandem cyclisations and both octahydroindolo[6,5,4-cd]indoles and decahydroindolo[4,3-fg]quinolines via triple radical cyclisations. A successful tandem double 5-exo-trig,6-endo-trig cyclisation of aryl radical generated from N-3-[3-(N-acetyl-N-allylamino)-2-bromophenyl]-5-(carbomethoxy)-1,4,5,6-tetrahydro-N-methylpyridine afforded methyl 1-acetyl-2,3,9,10-tetrahydrolysergate.


Journal of The Chemical Society, Chemical Communications | 1990

Synthesis of lysergic acid derivatives by triple radical cyclisation

David Cladingboel; Philip J. Parsons

The lysergic acid ring system, characteristic of the ergot alkaloids, is constructed from 2-bromoaniline derivatives by triple radical cyclisation, initiated with tri-n-butyltin hydride; formation of a 6- rather than a 5-membered D ring is controlled by a terminal phenylthio group.


Journal of Medicinal Chemistry | 2007

Discovery of Potent and Selective Adamantane-Based Small-Molecule P2X7 Receptor Antagonists/Interleukin-1β Inhibitors

Mark Furber; Lilian Alcaraz; Janice Bent; Armin Beyerbach; Keith Bowers; Martin Braddock; Moya Caffrey; David Cladingboel; John Collington; David Keith Donald; Malbinder Fagura; Frank Ince; Elizabeth Kinchin; Celine Laurent; Mandy Lawson; Timothy Jon Luker; Michael Mortimore; Austen Pimm; Robert J. Riley; Nicola J. Roberts; Mark J. Robertson; Jill Theaker; Philip Thorne; Richard Weaver; Peter J. H. Webborn; Paul Willis


Archive | 2004

Derives de 2-adamantyle en tant qu'antagonistes du recepteur p2x7

David Cladingboel; Rhonan Ford; Paul Willis


Archive | 2000

Püridiini uued derivaadid ja neid sisaldavad ravimkoostised

David Cheshire; David Cladingboel; Martin Cooper; David Norman Hardern; Simon Hirst; Carol Manners; Michael J. Stocks


Archive | 2000

Derives d'adamantane

Andrew Douglas Baxter; Thomas Mcinally; Michael Mortimore; David Cladingboel


Archive | 1998

Derivate des adamantan Derivatives of adamantane

Andrew Douglas Baxter; Stephen Brough; Thomas Mcinally; Michael Mortimore; David Cladingboel


Archive | 1998

Pyridinderivate und sie enthaltende pharmazeutische zubereitungen Pyridine derivatives and pharmaceutical preparations containing them

David Cheshire; David Cladingboel; Martin Cooper; David Norman Hardern; Simon Hirst; Carol Manners; Michael J. Stocks

Collaboration


Dive into the David Cladingboel's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge